caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1558473801

Mihaela NegulescuMD

NephrologyUncasville, CTI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Mihaela Negulescu's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 84 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
LAWRENCE AND MEMORIAL HOSPITAL, INC.3112,120
THE WILLIAM W BACKUS HOSPITAL2373,182
Altaf Rasool
Nephrology · Uncasville, CT
1351,403
DVA HEALTHCARE OF NORWICH LLC84468
SORRENTINO, JOHN72291
Valerie Popkin
Cardiology · Waterford, CT
58229
Quest Diagnostics Llc
Clinical Laboratory · Wallingford, CT
55225
DALAL, AJAY54240
Sheldon Robbins
Diagnostic Radiology · New London, CT
52261
Louis Mazzarelli
Diagnostic Radiology · New York, NY
49219
Mark Somers
Cardiology · Waterford, CT
48181
Roshanak Bagheri
Cardiology · Philadelphia, PA
47169
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
752
Unique beneficiaries
—
Total services
1,303
Distinct HCPCS
14
Medicare payment
$175K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 109 Nephrology providers in CT — above median (cohort median 1,019).
PRESCRIBING · PART D · 2024
Total Rx claims
959
Beneficiaries
—
Total drug cost
$38K
Distinct drugs
27
Brand share
10.6%
Top prescribed drugs
Calcitriol141 claims
Allopurinol87 claims
Amlodipine Besylate74 claims
Sevelamer Carbonate61 claims
Doxazosin Mesylate59 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
100.0
Cost
77.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$5
Payment records
2
By payment type
Education$5